The Zhitong Finance App learned that Novo Nordisk (NVO.US) rose more than 6% to $42.64 on Wednesday. According to the news, Novo Nordisk's financial report on November 4 shows that adjusted sales for the third quarter reached DKK 79.2 billion, higher than market expectations of 73.55 billion kroner; adjusted profit before interest and tax was 31.72 billion kroner, which also greatly exceeded expectations of 28.71 billion kroner.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.